FRIDAY, June 28, 20204 (HealthDay news) — An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free following treatment, a new trial shows. The combo drug, Kadcyla, is already approved to treat patients with advanced HER2-positive breast cancer, researchers said. The new results show that stage 1 breastContinue Reading

MONDAY, June 24, 2024 (HealthDay News) — Giving people with pancreatic cancer chemotherapy both before and after a tumor-removing surgery brought better outcomes than if they got the drugs only after the surgery, new research shows. Researchers at the Yale Cancer Center (YCC) and Yale School of Medicine focused onContinue Reading

FRIDAY, June 21, 2024 (HealthDay News) — An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma, researchers report.  The five-drug combination does not include chemotherapy. Rather, it simultaneously zeroes in on several molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors rely onContinue Reading

WEDNESDAY, June 19, 2024 (HealthDay News) — A new AI-driven blood test could improve detection of liver cancer, which is one of the most fatal cancers because early diagnosis is difficult. The test looks for “fusion genes” — two different genes that have become bound together, producing proteins that canContinue Reading